Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 28, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 1, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001093557-26-000124
Filed / recorded
Jun 1, 2026, 9:35 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
DEXCOM INC
Issuer CIK
1093557
Ticker
DXCM
Reporting person
Kyle Malady
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 28, 2026
Transaction code
A
Shares / units
5,575
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
28,242
Ownership form
Direct
Amendment
No
Footnotes from the filing
The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.